You are here: Industry Insights > vaccine

News List

Global COVID-19 fundraising meeting raises $6.9 billion, leaders want vaccine for all expresspharma
June 29, 2020
The money will be used for COVID-19 tests, treatments and vaccines, and also to support the world’s poorest and most marginalised communities.
Inovio gets $71 million from US defense department for COVID-19 vaccine device expresspharma
June 24, 2020
Inovio, which began human testing of its vaccine in April, said it expects to report interim results from the trial later this month, and added that it would begin mid-stage trials this summer.
Interdisciplinary consortium receives grant to develop next-generation cell-based cancer vaccines pharmaceutical-business-review
June 23, 2020
Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers. Access to these promising therapies is limited by the high costs of manufacturing at centralized locations.
Chinese researchers launch phase-2 human test for possible coronavirus vaccine expresspharma
June 23, 2020
IMBCAMS began a phase 2 human test for its experimental shot, which is among six possible vaccines Chinese scientists are testing in humans, following an on-going phase-1 study that has recruited about 200 participants since May.
Intravacc’s experimental whooping cough vaccine shows promising results in a preclinical study expresspharma
June 23, 2020
The study shows that intranasal immunization induced both excellent systemic and local immune responses, but also prevented colonization of the lung, trachea and nose.
Thai trials of COVID-19 vaccine reach make-or-break stage expresspharma
June 23, 2020
Thirteen monkeys were immunized and the next two weeks will be critical in determining whether researchers can proceed with further tests.
J&J Accelerates COVID-19 Vaccine Candidate americanpharmaceuticalreview
June 22, 2020
Johnson & Johnson announced through Janssen Pharmaceutical, it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant.
CureVac Receives Approval to Initiate Clinical Trial of SARS-CoV-2 Vaccine Candidate contractpharma
June 18, 2020
The Belgian Federal Agency for Medicines and Health Products (FAMHP) has approved the Phase 1 clinical trial for CureVac’s vaccine program to prevent SARS-CoV-2 infection. The trial will be conducted in Germany and Belgium.
EU calls for global alliance to buy COVID-19 vaccines up front expresspharma
June 18, 2020
It is planning to spend around $2.3 billion on the advance purchase of vaccines in testing on behalf of the 27 EU states.
Germany to invest €300m in CureVac’s mRNA platform technology pharmaceutical-technology
June 17, 2020
The German Federal Government is set to invest €300m in CureVac, a biotechnology company focused on using messenger RNA (mRNA) technology to develop drugs and vaccines.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page